These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 23218164)

  • 1. Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia.
    Andrade C
    J Clin Psychiatry; 2012 Nov; 73(11):e1362-4. PubMed ID: 23218164
    [No Abstract]   [Full Text] [Related]  

  • 2. Schizophrenia and obsessive-compulsive disorder.
    Devulapalli K; Nasrallah HA
    Am J Psychiatry; 2010 Nov; 167(11):1407-8. PubMed ID: 21041254
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitor syndrome: precipitated by concomitant clozapine?
    Lu ML; Lane HY; Chang WH
    J Clin Psychopharmacol; 1999 Aug; 19(4):386-7. PubMed ID: 10440475
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluvoxamine-clozapine dose-dependent interaction.
    Markowitz JS; Gill HS; Lavia M; Brewerton TD; DeVane CL
    Can J Psychiatry; 1996 Dec; 41(10):670-1. PubMed ID: 8978949
    [No Abstract]   [Full Text] [Related]  

  • 5. Sertraline in the treatment of clozapine-induced obsessive-compulsive behavior.
    Rahman MS; Grace JJ; Pato MT; Priest B
    Am J Psychiatry; 1998 Nov; 155(11):1629-30. PubMed ID: 9812137
    [No Abstract]   [Full Text] [Related]  

  • 6. Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features.
    Strous RD; Patel JK; Zimmet S; Green AI
    Am J Psychiatry; 1999 Jun; 156(6):973-4. PubMed ID: 10360153
    [No Abstract]   [Full Text] [Related]  

  • 7. Disinhibition as a side effect of treatment with fluvoxamine in pediatric patients with obsessive-compulsive disorder.
    Harris E; Eng HY; Kowatch R; Delgado SV; Saldaña SN
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):347-53. PubMed ID: 20807074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
    Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC
    J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obsessive-compulsive symptoms in clozapine-treated schizophrenic patients.
    Ertugrul A; Anil Yagcioglu AE; Eni N; Yazici KM
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):219-22. PubMed ID: 15823172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil and antipsychotic-induced sedation.
    DeQuardo JR
    J Clin Psychiatry; 2004 Feb; 65(2):278-9; author reply 279. PubMed ID: 15003090
    [No Abstract]   [Full Text] [Related]  

  • 11. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G; Albert U; Salvi V; Bogetto F
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating depression in schizophrenia.
    Lund BC; Perry PJ; Miller DD
    Am J Psychiatry; 2001 Sep; 158(9):1528-9. PubMed ID: 11532750
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic interactions of antidepressants.
    Richelson E
    J Clin Psychiatry; 1998; 59 Suppl 10():22-6. PubMed ID: 9720479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia].
    Scholl HP; Kasper S; Danos P; Höflich G; Möller HJ
    Nervenarzt; 1994 Jul; 65(7):478-81. PubMed ID: 7800092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of obsessive-compulsive symptoms in schizophrenia with a neuroleptic-selective serotonin reuptake inhibitor combination: two case reports.
    Sewell DD; Lopez WM; Paulsen J; Gilbert P
    J Nerv Ment Dis; 1994 Dec; 182(12):725-7. PubMed ID: 7989921
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced speech dysfluency and myoclonus preceding generalized tonic-clonic seizures in an adolescent male with schizophrenia.
    Horga G; Horga A; Baeza I; Castro-Fornieles J; Lázaro L; Pons A
    J Child Adolesc Psychopharmacol; 2010 Jun; 20(3):233-4. PubMed ID: 20578939
    [No Abstract]   [Full Text] [Related]  

  • 17. Clozapine-fluroxamine interaction.
    Markowitz JS
    Clin Neuropharmacol; 1997 Jun; 20(3):281-2. PubMed ID: 9197954
    [No Abstract]   [Full Text] [Related]  

  • 18. Obsessive-compulsive symptoms with risperidone.
    Mahendran R
    J Clin Psychiatry; 1999 Apr; 60(4):261-3. PubMed ID: 10221290
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serious drug interaction between clozapine-Leponex and fluvoxamine-Fevarin].
    Olesen OV; Starup G; Linnet K
    Ugeskr Laeger; 1996 Nov; 158(48):6931-2. PubMed ID: 8984760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessive-compulsive symptoms during treatment with clozapine in a patient with schizophrenia.
    Cheung EF
    Aust N Z J Psychiatry; 2001 Oct; 35(5):695-6. PubMed ID: 11551293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.